Log In
BCIQ
Print this Print this
 

Demser, metyrosine (ONO-5371)

  Manage Alerts
Collapse Summary General Information
Company Valeant Pharmaceuticals International Inc.
DescriptionTyrosine hydroxylase inhibitor
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationNeuroendocrine tumors
Indication DetailsTreat pheochromocytoma
Regulatory Designation
PartnerOno Pharmaceutical Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/22/2013

Undisclosed

Undisclosed

0

Get a free BioCentury trial today